Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FANCI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
WARS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ING1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AKAP10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WFS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PQBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRPF6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100506639 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAD50 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AVL9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EFCAB14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SH3GLB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIP4K2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DEDD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SP110 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on